SQDG
SQDG inhibits topoisomerase I and P-selectin receptor, exhibits anti-inflammatory, antiviral and antitumor activities. SQDG is a glycolipid that possesses sugar moieties in their head groups. SQDG is a membrane lipid that can be used to investigate the effects of structural lipid in LNP formulations[1][2][3].
Product Specifications
CAS Number
123036-44-2
UNSPSC
12352200
Target
Apoptosis; HSV; Liposome; MDM-2/p53; Topoisomerase
Type
Biochemical Assay Reagents
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sqdg.html
Purity
99.0
Solubility
DMSO : 1 mg/mL (ultrasonic; warming)
Smiles
CC/C=C\C/C=C\C/C=C\CCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCC)=O)CO[C@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CS(=O)(O)=O)=O
Molecular Formula
C43H76O12S
Molecular Weight
817.12
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
2,5-Dioxopyrrolidin-1-yl 23-oxo-4,7,10,13,16,19-hexaoxa-22-azaoctatriacontanoate
2,5-Dioxopyrrolidin-1-yl 23-oxo-4,7,10,13,16,19-hexaoxa-22-azaoctatriacontanoate
2,5-Dioxopyrrolidin-1-yl 23-oxo-4,7,10,13,16,19-hexaoxa-22-azaoctatriacontanoate
2,5-Dioxopyrrolidin-1-yl 23-oxo-4,7,10,13,16,19-hexaoxa-22-azaoctatriacontanoate
TNNI1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
